跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,617 条关于
“DIFF Biotech”
全部
4,617
临床试验
118
药物
768
机构
277
资讯
3,454
7个月前
DIFF Biotech's Novel Nasal Spray Influenza Vaccine Receives Clinical Trial Approval in China
去年
Pfizer Advances in C. diff Vaccine Development and Pneumococcal Shot Progress
去年
Recursion's AI-Driven C. diff Candidate REC-3964 Enters Phase II Trials
去年
RBX2660 Receives FDA Breakthrough Therapy Designation for Recurrent C. diff Infection
5个月前
Phase 3 C. diff Vaccine Trial Launches at University of Washington to Protect High-Risk Older Adults
去年
Recursion Pharmaceuticals Doses First Patient in Phase 2 Study of REC-3964 for Recurrent C. diff Infection
去年
Real-World Data Reinforces Efficacy of Live-jslm (Rebyota) for Recurrent C. difficile Infection
去年
C. diff Advocates Highlight Critical Role of Pharmacists and Public Health Infrastructure at National Summit
3个月前
RNA-Based Molecular Test More Accurately Distinguishes Active C. difficile Infection from Colonization
去年
GenScript Biotech and NSG Bio Form Strategic Partnership to Accelerate Biotech Innovation in Singapore
第 1 页,共 346 页
上一页
下一页